IgA reconstitution in IgA deficiency – experimental therapy to restore “healthy” microbiota ecology – IgARescue
Evolution has provided effective ways of protecting man from external dangers while prospering from opportunities. The gut microbiota is a complex mixture of microbes that are continuously challenging the integrity of the intestinal barrier while at the same time providing numerous metabolic advantages. The intestinal barrier integrity is ensured by various mechanisms including host antibodies in the form of secretory IgA (sIgA). sIgA binds microbes and regulate microbiota ecology. Patients suffering from IgA deficiency display altered microbiota ecology and increased risk of infection. Our project will provide preclinical evaluation of a therapeutic approach aiming to reconstitute IgA in immune deficient individuals. This will provide a better insight into the role of IgA in regulating host - gut microbiota interactions and potentially provide evidence for a protective therapy in immunodeficient pathologies, such as primary as well as corticosteroid induced immunodeficiencies.
Project coordination
Martin LARSEN (Centre d'Immunologie et de Maladies Infectieuses)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
GIMAP Groupe sur l'Immunité des Muqueuses et des Agents Pathogènes - EA3064
CIMI Centre d'Immunologie et de Maladies Infectieuses
MaaT MAAT PHARMA
Help of the ANR 512,601 euros
Beginning and duration of the scientific project:
December 2020
- 42 Months